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The cytosolic sensor MDA5 is crucial for antiviral
innate immune defense against various RNA
viruses including measles virus; as such, many
viruses have evolved strategies to antagonize the
antiviral activity of MDA5. Here, we show that
measles virus escapes MDA5 detection by targeting
the phosphatases PP1a and PP1g, which regulate
MDA5 activity by removing an inhibitory phosphory-
lation mark. The V proteins of measles virus and the
related paramyxovirus Nipah virus interact with
PP1a/g, preventing PP1-mediated dephosphoryla-
tion of MDA5 and thereby its activation. The PP1
interaction with the measles V protein is mediated
by a conserved PP1-binding motif in the C-terminal
region of the V protein. A recombinant measles virus
expressing a mutant V protein deficient in PP1 bind-
ing is unable to antagonize MDA5 and is growth
impaired due to its inability to suppress interferon in-
duction. This identifies PP1 antagonism as a mech-
anism employed by paramyxoviruses for evading
innate immune recognition.
INTRODUCTION
Pattern recognition receptors (PRRs) are critical components
of the host’s innate immune sensing apparatus for detecting
microbial pathogens in both nonimmune and immune cells.
PRRs recognize conserved pathogen-associated molecular
patterns (PAMPs) and then activate signaling cascades leading
to the production of proinflammatory cytokines and type I
interferons (IFN-a/b), ultimately resulting in an antiviral state
and activation of adaptive immune responses (Creagh and
O’Neill, 2006; Takeuchi and Akira, 2010). Retinoic acid-inducible
gene-I (RIG-I) and melanoma differentiation-associated gene
5 (MDA5), the best characterized members of the RIG-I-like
receptor (RLR) family, play an essential role in cytosolic detec-
tion of RNA viruses (Kato et al., 2006; Loo and Gale, 2011;
Yoneyama et al., 2004).CRIG-I is activated by 50 triphosphate short dsRNA structures
present in negative-strand RNA viruses as well as polyuridine/
cytosine motifs in the positive-strand RNA of hepatitis C virus
(Hornung et al., 2006; Pichlmair et al., 2006; Saito et al., 2008).
In contrast, MDA5 recognizes long dsRNA or RNA web struc-
tures produced during the replication cycle of picornaviruses
(Kato et al., 2006). Recent studies have also provided evidence
that MDA5 acts in concert with RIG-I to respond to certain flavi-
viruses, reoviruses, and paramyxoviruses, such asmeasles virus
(MV) and Sendai virus (SeV) (Gitlin et al., 2010; Ikegame et al.,
2010; Loo et al., 2008).
Despite their differences in ligand specificity, RIG-I and MDA5
share a common domain structure consisting of tandem cas-
pase activation and recruitment domains (CARDs) at the N termi-
nus that are necessary and sufficient for signal transduction, as
well as a helicase/ATPase domain and a C-terminal domain
(CTD), both of which are important for RNA recognition (Cui
et al., 2008; Yoneyama et al., 2004). Once activated, RIG-I and
MDA5 form a complex with the mitochondrial-localized adaptor
molecule MAVS/VISA/IPS-1/Cardif, resulting in downstream
signaling to orchestrate activation of the transcription factors
NF-lB, AP1, and IRF3/7, leading to IFN-a/b gene expression
(Loo and Gale, 2011).
Recent studies demonstrated that host cells are equipped
with an elegant system for regulating RLR-induced signaling to
avoid aberrant or premature immune activation (Eisena¨cher
and Krug, 2012; Loo andGale, 2011). Posttranslational modifica-
tions of the N-terminal CARDs as well as conformational
changes induced by the CTD have been shown to play an impor-
tant role in regulating RLR signaling activities (Gack et al., 2007;
Saito et al., 2007). Recently, we demonstrated that RIG-I and
MDA5 signaling activities are tightly controlled by an intricate
balance of phosphorylation and dephosphorylation of their
CARDs and identified the phosphatase PP1—specifically PP1a
and PP1g isoforms—as key regulators of RIG-I and MDA5 acti-
vation (Gack et al., 2010; Maharaj et al., 2012; Nistal-Villa´n et al.,
2010; Wies et al., 2013). In uninfected cells, RIG-I and MDA5
signaling is prevented by constitutive phosphorylation of specific
serine/threonine residues located in the CARDs: serine 8 (S8)
and threonine 170 (T170) in RIG-I and serine 88 (S88) in MDA5.
Upon binding to RNA ligands, RIG-I and MDA5 are dephos-
phorylated by PP1a/g, allowing RLR interaction with MAVS
and IFN-a/b induction (Wies et al., 2013).ell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc. 19
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Paramyxovirus V Proteins Target PP1 to Block MDA5Paramyxoviruses are enveloped, nonsegmented, negative-
strand RNA viruses comprising various human and animal path-
ogens including MV, mumps virus, parainfluenza virus 5 (PIV5),
and the newly emerging Nipah (NiV) and Hendra viruses. To
combat recognition and clearance by the immune system, these
viruses have evolved sophisticated mechanisms to antagonize
both IFN induction and IFN receptor signal transduction (Bowie
and Unterholzner, 2008; Horvath, 2004). This immunosuppres-
sion is particularly well known for MV; in fact, many cases ofmor-
tality associated with MV infection are due to its potent inhibition
of innate and adaptive immune responses (Moss et al., 2004).
The IFN antagonistic activity of paramyxoviruses is due to one
or more gene products of the paramyxovirus P/C/V gene, which
encodes the essential phospho (P) protein and, through alterna-
tive reading frames or RNA editing, the virulence factors C, V,
and/or W proteins. Of the three, the V protein is the best charac-
terized IFN antagonist. A major target of paramyxovirus V pro-
teins is the immune sensor MDA5 (Andrejeva et al., 2004; Childs
et al., 2007; Parisien et al., 2009; Rodriguez and Horvath, 2013);
however, the molecular mechanisms by which the V proteins
inhibit MDA5 activity have only begun to be elucidated. It has
been shown that the V proteins physically interact with the heli-
case domain of MDA5, inhibiting its ATPase activity and thereby
MDA5 filament formation (Childs et al., 2009). Recently, cocrys-
tal structure analysis of porcine MDA5 and the V protein of PIV5
provided evidence that the V protein inhibits the ATP hydrolysis
activity of MDA5 through structural unfolding (Motz et al., 2013).
Given the large diversity of IFN antagonistic strategies employed
by members of the paramyxovirus family, the mechanism of
MDA5 inhibition by their V proteins is likely more complex than
the present data suggest.
Here we identify amechanism ofMDA5 inhibition employed by
MV and NiV in which their V proteins target PP1a and PP1g, two
essential activators of MDA5 signaling. PP1a/g binding of the V
protein prevents dephosphorylation of MDA5 and thereby its
activation. Generation of a PP1 binding-deficient recombinant
(r) MV demonstrates that PP1 antagonism by the V protein is
an important mechanism for suppressing MDA5-mediated type
I IFN induction.
RESULTS
The V Proteins of Measles and Nipah Virus Suppress
MDA5 S88 Dephosphorylation
MDA5 signaling activity is tightly regulated by constitutive phos-
phorylation, keeping it inactive. Upon viral RNA sensing,MDA5 is
activated via dephosphorylation by PP1, allowing innate immune
signaling (Wies et al., 2013). We hypothesized that viruses may
modulate this intricate balance of phosphorylation/dephosphor-
ylation to prevent MDA5 activation and thus escape innate
immune detection. To address this, we tested three RNA viruses,
all known to be sensed byMDA5, for their effect on the S88 phos-
phorylation of FLAG-MDA5 by immunoblot (IB) using a phospho-
(p)-S88-MDA5-specific antibody: encephalomyocarditis virus
(EMCV, a picornavirus); dengue virus (DenV, a flavivirus); and
MV (a paramyxovirus) (Figure 1A). Infection with EMCV and
DenV induced MDA5 S88 dephosphorylation, indicative of
MDA5 activation (Figure 1A). In striking contrast, the Edmonston
(Ed) vaccine strain of MV (MVEd) did not induce any change in20 Cell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc.MDA5 S88 phosphorylation levels, even at a high multiplicity of
infection (moi) (Figure 1A), suggesting that MVEd modulates the
MDA5 phosphorylation state. However, MVEd triggered RIG-I
S8 dephosphorylation as efficiently as SeV, a virus known to
induce RIG-I activation (Figure 1B). In line with this, while trans-
fection of polyinosine-polycytidylic acid (poly[I:C]), a potent
MDA5 agonist, efficiently triggered S88 dephosphorylation of
endogenousMDA5 in primary human dendritic cells (DCs), infec-
tionwith an enhanced green fluorescent protein (EGFP)-express-
ing rMV based on thewild-type (WT) Khartoum-Sudan (KS) strain
(rMVKSEGFP[3]) did not change the MDA5 S88 phosphorylation
levels compared to uninfected cells (Figure 1C). However, rMVKS
infection efficiently induced RIG-I S8 and T170 dephosphoryla-
tion in DCs at this time point (Figure 1C). Collectively, these
results suggest that MV, but not DenV and EMCV, blocks the
dephosphorylation of the sensor MDA5.
The V proteins of various paramyxoviruses, including MV, have
been shown to interact with and inhibit MDA5 (Andrejeva et al.,
2004; Childs et al., 2007); however, the molecular mechanism of
this viral antagonism has only begun to be elucidated. We there-
fore sought to determine whether the MDA5 phosphorylation-
modulating activityofMVwascausedby theVprotein. Toaddress
this, we transfected increasing amounts of the MV V protein
(MV-V) together with FLAG-MDA5 (Figure 1D). Overexpressed
FLAG-MDA5, in contrast to endogenous MDA5, is not fully phos-
phorylateddue toa low-level, constitutivebinding toPP1a/g (Wies
et al., 2013), allowing examination of interference with the MDA5
S88 dephosphorylation by PP1. Indeed, MV-V strongly enhanced
MDA5 S88 phosphorylation in a dose-dependent manner, indi-
cating interference with MDA5 dephosphorylation. The V protein
ofNiV (NiV-V)also robustly enhancedMDA5S88phosphorylation,
while thatofPIV5 (PIV5-V)onlymarginally increased theS88phos-
phorylation levels (Figures 1E and S1A, available online). Notably,
MV-V and NiV-V did not affect RIG-I CARD phosphorylation, indi-
cating that the V proteins specifically modulate the phosphoryla-
tion state of MDA5, but not RIG-I (Figures 1F and S1B).
Paramyxovirus V proteins have been reported to bind to the
helicase domain of MDA5, leading to disruption of the ATP hy-
drolysis site (Motz et al., 2013). Residue R806 in MDA5 was
shown to be critical for V-MDA5 interaction as mutation to
leucine (R806L) abrogated or strongly reduced the binding of
paramyxovirus V proteins to the helicase (Motz et al., 2013; Ro-
driguez and Horvath, 2013). To address whether modulation of
MDA5 CARD phosphorylation and disruption of ATP hydrolysis
are dependent or independent activities of the V protein, we
determined the effect of the V protein on S88 phosphorylation
of the MDA5 R806L mutant (Figure S1C). As with WT MDA5,
ectopic expression of MV-V and NiV-V strongly increased S88
phosphorylation of MDA5 R806L, while PIV5-V had only a mar-
ginal effect (Figure S1C). These results indicate that the ability
of MV-V and NiV-V to modulate MDA5 phosphorylation is
independent of binding to the ATP-hydrolysis domain.
In uninfected cells, MDA5 S88 phosphorylation prevents
MDA5 binding to the downstream adaptor MAVS. Viral RNA
binding induces S88 dephosphorylation, allowing MAVS binding
and leading to IFN gene expression (Wies et al., 2013). We there-
fore examined the effects of MV-V and NiV-V, which robustly
increased MDA5 S88 phosphorylation, on the CARD-CARD
interaction between MDA5 and MAVS (Figure 1G). In the
A B C
D E F
G H I
Figure 1. The Paramyxovirus V Protein Inhibits MDA5 S88 Dephosphorylation
(A) S88 phosphorylation of FLAG-MDA5 in HEK293T infected with MVEd (moi 1 or 3) or DenV (moi 5) for 24 hr, or with EMCV (moi 0.5) for 3 hr, assessed by IP with
anti-FLAG, followed by immunoblot (IB) with anti-pS88-MDA5. Efficient MV infection was determined by IB with anti-MV nucleoprotein (MV-N).
(B) S8 phosphorylation of FLAG-RIG-I inHEK293T, either left uninfected (Mock) or infectedwithMVEd (moi 3) for 8 or 24 hr, or SeV (50 hemagglutinin units [HAU]/ml)
for 24 hr, assessed by IPwith anti-FLAG, followedby IBwith anti-pS8-RIG-I. Expression ofMV-Nwas determined as in (A); two different blot exposures are shown.
(C) Endogenous MDA5 S88 and RIG-I S8 or T170 phosphorylation in human DCs either unstimulated, treated with poly(I:C)-LyoVec for 3 hr (upper panels), or
infected with rMVKSEGFP(3) WT for 16 hr (lower panels), determined by flow cytometry using phospho-specific pS88-MDA5, pS8-RIG-I, and pT170-RIG-I
antibodies. Data are representative of three individual donors.
(D) S88 phosphorylation of FLAG-MDA5 in HEK293T upon expression of increasing amounts of HA-MV-V protein, assessed as in (A).
(E and F) IB analysis of FLAG-MDA5S88 (E) or FLAG-RIG-I S8 (F) phosphorylation upon expression of HA-tagged V proteins, determined by IPwith anti-FLAG and
IB using the indicated phospho-antibodies.
(G) Interaction of GST-MDA5-2CARD with MAVS-CARD-PRD-FLAG in the presence of HA-MV-V or HA-NiV-V, assessed by GST pull down (GST-PD).
(H and I) IFN-b luciferase activity in HEK293T cells transfected with GST-MDA5 2CARD (H) or FLAG-MDA5 (I) together with vector, MV-V, or NiV-V, normalized to
constitutive pGK-b-gal. The results are expressed as means ± SD (n = 3). *p < 0.05; **p < 0.01. See also Figure S1.
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Paramyxovirus V Proteins Target PP1 to Block MDA5absence of the V protein, GST-MDA5 2CARD efficiently inter-
acted with the CARD-proline-rich domain of MAVS (MAVS-
CARD-PRD); however, coexpressed MV-V or NiV-V potently
diminished this interaction (Figure 1G). Crucially, the MV-V and
NiV-V proteins did not affect the binding of MAVS-CARD-PRD
to an MDA5 mutant in which the S88 residue was replaced
with alanine (GST-MDA5 2CARD S88A), reinforcing that the
inhibition of MDA5-MAVS binding by the V proteins is a direct
effect of their abilities to enhance MDA5 S88 phosphorylation
(Figure S1D). Consistent with their inhibitory effects on MDA5-
MAVS binding, MV-V and NiV-V markedly suppressed theCIFN-b promoter activation induced by MDA5 2CARD or full-
length MDA5 (Figures 1H and 1I). Collectively, these results
indicate that the V proteins of MV and NiV inhibit MDA5 S88
dephosphorylation, thereby suppressing MDA5-MAVS binding
and downstream signaling.
The V Proteins of MV and NiV Interact with the
Phosphatases PP1a/g
To elucidate the mechanism by which MV-V and NiV-V prevent
MDA5 S88 dephosphorylation, we tested their potential interac-
tion with PP1. Coimmunoprecipitation (coIP) showed that MV-Vell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc. 21
Figure 2. The V Proteins of MV and NiV Bind to PP1a/g
(A andB)EndogenousPP1a (A) orPP1g (B) binding to the indicatedHA-tagged (A) or FLAG-tagged (B) Vproteins in transfectedHEK293Tcells, determinedbycoIP.
(C) Confocal scanning laser images of HA-MV-V (green) and FLAG-PP1g (red) in transfected HeLa cells. Nuclei were stained with DAPI (blue). Colocalization
of MV-V and PP1g was assessed by histogram profiles of merged images.
(D) coIP of HA-tagged PP1a, PP1b, or PP1g and FLAG-MV-V in transfected HEK293T cells.
(E) Binding of FLAG-MV-V to HA-PP1g in transfected Ifih1/ MEFs, assessed by IP with anti-FLAG and IB using anti-HA. See also Figure S2.
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Paramyxovirus V Proteins Target PP1 to Block MDA5and NiV-V bound efficiently to endogenous PP1a and PP1g (Fig-
ures 2A and 2B). In contrast, PIV5-V did not interact with PP1a/g
(Figures 2A and S2A). Confocal microscopy showed that MV-V
preferentially localized to the cytoplasm, with a minor fraction
localized to the nucleus, whereas PP1g was localized in both
the nucleus and cytoplasm (Figure 2C). When both proteins
were expressed together, however, PP1g relocalized to the
cytoplasm, where it extensively colocalized with MV-V at mito-
chondria-associated membranes, a subcellular compartment
important for MDA5 signaling (Figures 2C and S2B). Further-
more, MV-V bound specifically to PP1a and PP1g, which de-
phosphorylate MDA5, but not to PP1b, which is not involved in
innate immune signaling (Wies et al., 2013) (Figure 2D). To
further characterize the PP1-V interaction, we asked whether
their binding is mediated by MDA5. To this end, we determined
the binding of MV-V to PP1 in mouse embryonic fibroblasts
(MEFs) derived from Mda5-deficient (Ifih1/) mice (Figure 2E).
MV-V bound efficiently to PP1 in Ifih1/ cells, suggesting that
the binding between the V protein and PP1 is not mediated by
MDA5 and thus likely to be a direct interaction. These results
indicate that the V proteins of MV and NiV, but not that of
PIV5, efficiently interact with the phosphatases PP1a and PP1g.22 Cell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc.The V Protein Inhibits the PP1-MDA5 Interaction and Is a
Substrate for Dephosphorylation by PP1
To address the mechanism by which the V protein interaction
with PP1a/g prevents MDA5 dephosphorylation, we asked
whether the MV-V protein (i) inhibits PP1’s enzymatic
activity, (ii) blocks the interaction of PP1 with MDA5, and
(iii) serves as a substrate for PP1-mediated dephosphorylation.
As neither MV infection nor MV-V expression suppressed RIG-I
dephosphorylation by PP1a/g (Figures 1B and 1F), it is
unlikely that the V protein inhibits the enzymatic activity of
PP1. To test whether the V protein competes with MDA5 for
PP1 binding, we first compared the PP1a/g binding of MDA5
and MV-V (Figure 3A). This showed that MV-V had a stronger
association with PP1 than did MDA5. Next, we determined
the binding of endogenous MDA5 to PP1 induced by poly(I:C)
in the presence or absence of MV-V (Figure 3B). Poly(I:C)
stimulation efficiently triggered PP1 binding to MDA5 in the
absence of MV-V; in contrast, no MDA5-PP1 interaction was
observed in poly(I:C)-stimulated cells expressing MV-V (Fig-
ure 3B). Finally, we examined endogenous PP1-MDA5 binding
in poly(I:C)-stimulated or rMVKSEGFP(3)-infected A549 lung
epithelial cells stably expressing the entry receptor for WT
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Figure 3. The V Protein Inhibits PP1 Binding
to MDA5 and Serves as a PP1 Substrate
(A) Binding of FLAG-MDA5 or FLAG-MV-V to HA-
PP1a and HA-PP1g in transfected HEK293T cells,
determined as described in Figure 2E.
(B) Endogenous MDA5-PP1g binding in mock-
treated or poly(I:C)-stimulated HEK293T cells,
transfected with vector or FLAG-MV-V, assessed
by IP with anti-MDA5, followed by IB with anti-
PP1g.
(C) Endogenous MDA5-PP1a binding in mock-
treated, poly(I:C)-stimulated, or rMVKSEGFP(3)-
infected A549-hCD150 cells, determined by coIP.
Efficient MV infection was determined by IB with
anti-MV-N (two different blot exposures are
shown).
(D) In vitro dephosphorylation of FLAG-MV-V by
purified PP1a, assessed by IB analysis using anti-
pSer. See also Figure S3.
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Paramyxovirus V Proteins Target PP1 to Block MDA5strains of MV, human (h) CD150 (A549-hCD150) (Figure 3C).
While poly(I:C) stimulation increased PP1 binding to MDA5,
there was a near-complete loss of PP1-MDA5 interaction in
rMVKSEGFP(3)-infected cells (Figure 3C).
Paramyxovirus P and V proteins are phosphorylated at multi-
ple Ser/Thr sites (Shiell et al., 2003). The kinases responsible
for V protein phosphorylation have been identified (Lu et al.,
2008; Ludlow et al., 2008; Pfaller and Conzelmann, 2008), but
the phosphatase(s) responsible for its dephosphorylation are
unknown. We thus tested whether MV-V, upon binding to PP1,
serves as a substrate for dephosphorylation by PP1. We first
determined the phosphorylation of FLAG-MV-V after treatment
with phosphatase inhibitors specific for PP1 and/or the related
phosphatase PP2A (Figure S3A). This showed that specific in-
hibitors of both PP1/PP2A (Calyculin A and Cantharidic acid),
but not the PP2A-specific inhibitor Endothall, or an alkaline
phosphatase inhibitor (Bromotetramisole), greatly enhanced
the phosphorylation of MV-V, evident from a stronger signal
in IB using a pan-phospho-Ser antibody, as well as a shift
of the bands of MV-V, representing its phosphorylated forms
(Figure S3A). In support of this, while treatment with Cantharidic
acid at concentrations inhibiting only PP2A did not affect
the phosphorylation state of MV-V, high concentrations of Can-
tharidic acid also blocking PP1 activity induced a shift in the
multiple-band pattern of MV-V, indicating its enhanced phos-
phorylation (Figure S3B). Finally, purified PP1a efficiently de-
phosphorylated MV-V in an in vitro dephosphorylation assay,
demonstrating direct enzymatic activity of PP1 toward the V pro-
tein (Figure 3D). Together, these results indicate that the MV-V
protein blocks PP1 binding to MDA5 and serves as a substrate
for PP1-mediated dephosphorylation, preventing MDA5 S88
dephosphorylation.Cell Host & Microbe 16,APP1Binding-Deficient VProtein Is
Unable to Inhibit MDA5
Dephosphorylation but Retains
MDA5 Binding and STAT Inhibition
Activities
We next sought to identify the site in the V
protein that is necessary for PP1 binding.The paramyxovirus V protein is expressed through RNA editing
of the P/C/V gene (Cattaneo et al., 1989; Thomas et al., 1988).
As such, it shares the N-terminal sequence (VN) with the P and
W proteins but has a unique, cysteine-rich C-terminal domain
(VC), which is responsible for many of its specific effector func-
tions (Figure 4A). We thus determined the PP1-binding capacity
of the P/V/W-shared VN and the unique VC of theMV-V andNiV-V
proteins. coIP studies revealed that, specifically, the MV-VC and
NiV-VC bound to PP1, while there was no interaction of PP1 with
their VN domains (Figure 4B). Consistent with this binding mode,
ectopic expression of MV-VC or NiV-VC fragments was sufficient
to enhance MDA5 S88 phosphorylation in a dose-dependent
manner (Figures S3C and S3D).
A hallmark of PP1-binding proteins is the presence of defined
PP1-binding motifs (Roy and Cyert, 2009). Indeed, sequence
alignment of the VC of several paramyxoviruses revealed that
MV-V harbors a canonical PP1-binding motif, R/K-x(0,1)-V/I-x-
F/W/Y (288RIWY291), in the extreme C-terminal portion of VC
(from now on referred to as C-terminal tail) (Figure 4C, upper
panel). This PP1-binding motif was conserved among various
vaccine and WT strains of MV (Figure S4). In contrast, no con-
ventional PP1-binding motif was identified in the VC of the other
paramyxoviruses.
To determine the role of PP1 binding for MDA5 antagonism by
the MV-V protein, key residues in the identified PP1-binding
motif were mutated to alanine (MV-V AIAA). In addition, a trunca-
tion mutant of MV-V was generated in which the C-terminal tail
region (aa 284–299) containing the PP1 motif was deleted
(MV-V Dtail) (Figure 4C, lower panel). These mutant V proteins
were tested for their PP1-binding abilities (Figure 4D). While
MV-V WT efficiently interacted with PP1, the MV-V AIAA and
Dtail mutants showed a reduced and near-complete loss of19–30, July 9, 2014 ª2014 Elsevier Inc. 23
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Figure 4. PP1 Binding of the Measles V Protein Is Required for Its Inhibitory Effect on MDA5 S88 Dephosphorylation
(A) Domain structures of the paramyxovirus P and V proteins and schematic representation of GST-fused truncation constructs of MV-V and NiV-V. Numbers
indicate amino acids.
(B) Binding of HA-PP1g to GST-fused VC or VN of MV or NiV in transfected HEK293T cells, assessed by GST-PD and IB using anti-HA.
(C) Top: protein sequence alignment of the VC of paramyxoviruses. Alignment was performed using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Asterisks (*) indicate a single, fully conserved residue. Colons (:) indicate conservation between groups of strongly similar properties, and periods (.) indicate
conservation between groups of weakly similar properties. Conserved residues of the zinc-finger motif responsible for MDA5 interaction are highlighted in gray.
Bottom: protein sequences of the MV-Vc WT, AIAA, and Dtail mutant. The identified PP1-binding motif in MV-Vc is indicated (red box). Numbers indicate amino
acids.
(D) Interaction of HA-PP1g to GST-fused MV-Vc WT or mutant proteins in transfected HEK293T cells, determined by GST-PD.
(E) S88 phosphorylation of FLAG-MDA5 in HEK293T expressing HA-tagged MV-V WT or mutant proteins, analyzed by IP.
(F) Binding of FLAG-MDA5 to HA-MV-V WT or mutant proteins, determined by coIP. See also Figures S3–S5.
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Paramyxovirus V Proteins Target PP1 to Block MDA5PP1 binding, respectively (Figure 4D). Consistent with its abol-
ished PP1-binding ability, the MV-V Dtail protein did not inhibit
PP1-MDA5 binding, nor did it block MDA5 S88 dephosphoryla-
tion; in contrast, MV-V WT robustly enhanced MDA5 phosphor-
ylation, indicative of inhibition of MDA5 dephosphorylation, while
the AIAAmutant only slightly enhanced MDA5 S88 phosphoryla-
tion (Figures 4E and S5A). Together, these results identify a clas-
sical PP1-binding motif in the C-terminal tail region of the MV-V
protein, which is necessary for PP1 binding and suppression of
MDA5 CARD dephosphorylation.
To further characterize the PP1 binding-defective MV-V
mutant proteins, we first tested their abilities to bind MDA5, an
activity mediated by conserved histidine and cysteine residues
in the VC domain (Figure 4C, upper panel). In contrast to their24 Cell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc.defective PP1-binding abilities, MV-V AIAA and Dtail mutants
interacted with MDA5 as efficiently as MV-V WT (Figure 4F).
Furthermore, MV-V is known to prevent the nuclear transloca-
tion of signal transducers and activators of transcription
(STAT) proteins to suppress IFN receptor signal transduction
(Palosaari et al., 2003). Thus, we also tested the MV-V AIAA
and Dtail mutant proteins for their abilities to block STAT2 nu-
clear translocation as compared to MV-V WT. Ectopically ex-
pressed MV-V AIAA and Dtail proteins prevented STAT2 nuclear
translocation as effectively as MV-V WT (Figure S5B). This dem-
onstrates that a mutant V protein in which the PP1-binding motif
is deleted is unable to bind PP1 and inhibit PP1-mediated MDA5
dephosphorylation but retains MDA5 binding and STAT
inhibition.
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Figure 5. A rMVExpressing aPP1Binding-DeficientMutant VProtein ShowsDiminishedReplication and IFNAntagonism inHuman Epithelial
Cells
(A) Replication of rMVKSEGFP(3) WT and VDtail viruses in Vero-hCD150 cells infected at an moi of 0.02. Viral titers were determined at 60 h.p.i. and are expressed
as mean 50% tissue culture infectious dose (TCID50/ml) ± SD (n = 3). n.s., not statistically significant.
(B) A549-hCD150 cells were infected with WT or VDtail virus (moi 0.02). Virus titers in the supernatant were determined by endpoint titration in Vero-hCD150 cells
and expressed as TCID50/ml.
(C) Bright-field images of A549-hCD150 cells infected with WT or VDtail virus at 48 h.p.i. and 60 h.p.i.
(D) Confocal microscopy images of endogenous IRF3 (red) in rMVKSEGFP(3) WT or VDtail virus-infected A549-hCD150 cells (green) at 18 h.p.i. Nuclei were
stained with DAPI (blue). Quantification of the percentage of cells with nuclear or cytoplasmic IRF3 (200 cells counted) (right).
(E) A549-hCD150 cells were infected with WT or VDtail virus (moi 0.05). After 24 hr, total RNA was extracted, and transcript levels of Ifnb1 and ISGs were
determined by quantitative real-time PCR. Transcript levels were normalized to Gapdh and are expressed as fold levels compared to mock-infected cells. Data
are expressed as means ± SD (n = 3). **p < 0.01. See also Figure S6.
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Paramyxovirus V Proteins Target PP1 to Block MDA5PP1 Antagonism Is Required for Inhibition of Type I IFN
Induction and Optimal Replication of MV in Epithelial
Cells
To assess the role of PP1 antagonism by the MV-V protein in
innate immune escape of MDA5-mediated IFN induction, we
sought to construct an rMV that expresses a mutant V protein
deficient in PP1 binding. Based on our biochemical characteriza-
tion of the MV-V Dtail mutant protein, we argued that a rMV
expressing a Dtail V protein will reveal the contribution of PP1
antagonism to IFN suppression and virus replication. We there-
fore designed a cloning strategy that, by introducing two stop
codons in the P/C/V gene, resulted in the deletion of the C-termi-
nal tail region (aa 288–299) of the MV-V protein while leaving
P protein expression unaffected (Figure S6A). Using reverse ge-
netics methodology as previously described (Lemon et al.,
2011), we then generated an EGFP-expressing rMVKS harboring
the MV-VDtail (rMVKSEGFP[3]-VDtail, referred to as VDtail virus).
We first examined the replication of the VDtail virus compared to
the parental rMVKSEGFP(3) WT virus (referred to as WT virus)
in Vero cells, which are IFN defective (Figure 5A). Both virusesCreplicated with comparable efficiencies, indicating that the
VDtail virus does not have a general growth defect (Figure 5A).
In striking contrast, the VDtail virus exhibited profoundly reduced
replication capacity compared to WT virus in A549-hCD150 lung
epithelial cells, which have an intact IFN system: the titers of the
VDtail virus were reduced by 2 and 3 logs compared to WT
virus at 60 hr postinfection (h.p.i.) and 72 h.p.i., respectively. At
later time points, the VDtail virus was not detectable, whereas
the WT virus still replicated efficiently (Figure 5B). Depletion
of endogenous MDA5 enhanced the replication of the VDtail
virus to titers comparable to those of WT virus, indicating that
the reduced replication capacity of the VDtail virus in A549-
hCD150 cells is indeed due to its inability to antagonize MDA5
(Figures S6B and S6C). Consistent with its impaired replication,
the VDtail virus had a greatly reduced ability to induce syncytium
formation and to cause cell death of A549-hCD150 cells; in
contrast, cells infected with the WT virus formed large syncytia
and died more rapidly (Figure 5C).
We argued that the growth defect of the VDtail virus in A549-
hCD150 cells is due to its diminished ability to suppress theell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc. 25
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Figure 6. The VDtail rMV Is Defective in
MDA5 Suppression and IFN Antagonism in
Primary Human DCs
(A) Primary human DCs were either DMSO treated
or preincubated with Raf-1 inhibitor GW5074 for
2 hr, and then infected with WT or VDtail virus (moi
0.5). Phosphorylation of endogenous MDA5 S88
(top), RIG-I S8 (middle), and RIG-I T170 (bottom)
was determined at 8 h.p.i. (left) and 16 h.p.i. (right)
by flow cytometry using phospho-specific pS88-
MDA5, pS8-RIG-I, and pT170-RIG-I antibodies.
Data are representative of three independent
donors.
(B–D) DCs that had been either DMSO treated or
preincubated with GW5074 for 2 hr were infected
with WT or VDtail virus (moi 0.5). Ifnb1 (B),Mx1 (C),
and Isg15 (D) mRNA levels were determined by
qRT-PCR at 24 h.p.i. Data are pooled from three
independent donors (B and C) or two independent
donors (D) and presented as means ± SD. *p <
0.05; n.s., not statistically significant.
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we determined the abilities of WT and VDtail virus to induce
the nuclear translocation of IRF3, a transcription factor required
for type I IFN gene expression. Infection with the VDtail virus effi-
ciently triggered nuclear translocation of endogenous IRF3,
whereas cells infected with WT virus exhibited primarily cyto-
plasmic IRF3 localization, comparable to uninfected cells (Fig-
ure 5D). Consistently, infection with the VDtail virus resulted
in significantly higher mRNA levels of Ifnb1 and the interferon-
inducible genes (ISGs), Mx1, Oas1, Isg15, and Ifi16, compared
to infection with WT virus (Figure 5E). Taken together, these
results show that a rMV harboring a mutant V protein that is defi-
cient in PP1 binding efficiently induces IRF3-mediated type I IFN
induction in lung epithelial cells and thus has impaired growth
kinetics.
The PP1 Binding-Deficient VDtail Virus Is Unable to
Suppress MDA5 S88 Dephosphorylation and Type I IFN
Induction in Primary Human DCs
After MV infection of the lung, DCs are among the first cells that
become infected (Moss et al., 2004). Thus, we investigated
whether MV, using its V protein, also targets PP1a/g in DCs to
evade detection by MDA5. We determined the abilities of the
VDtail virus and WT virus to modulate MDA5 S88 phosphoryla-
tion in primary human DCs at early (8 h.p.i.) and late (16 h.p.i.)
time points during infection (Figure 6A, upper panel). In DCs
infected with the WT virus, MDA5 remained phosphorylated
at both time points, indicating that MV blocks MDA5 phosphor-
ylation early and late during infection. In contrast, in VDtail virus-
infected cells MDA5 was in the dephosphorylated, active state
at 16 h.p.i., indicating an inability to block MDA5 dephosphory-
lation (Figure 6A, upper right panel). Interestingly, at 8 h.p.i.26 Cell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc.MDA5 was phosphorylated in the VDtail
virus-infected cells. RIG-I was also kept
in the S8/T170-phosphorylated, inactive
state at 8 h.p.i. in WT and VDtail virus-in-
fected cells (Figure 6A, middle and lower
left panels). In contrast toMDA5 suppres-sion, the inhibition of RIG-I dephosphorylation was transient and
not affected by the V protein, as RIG-I was fully dephosphory-
lated at 16 h.p.i. in both WT and VDtail virus-infected cells
(Figure 6A, middle and lower right panels). These results demon-
strate that in DCs, MV uses V-dependent and V-independent
mechanisms for preventing RLR activation: while the V-depen-
dent inhibitory mechanism specifically targets MDA5, the V-in-
dependent mechanism blocks both RIG-I and MDA5 activation,
specifically early during infection (Mesman et al., 2014). This
early, V-independent inhibitory mechanism of MV is triggered
via DC-specific DC-SIGN signaling and subsequent Raf-1 kinase
activation, as treatment with the Raf-1 inhibitor GW5074 induced
dephosphorylation of MDA5 and RIG-I at 8 h.p.i. but, notably,
had no effect on both RLRs at 16 h.p.i. (Figure 6A). Our study,
combined with the results by Mesman et al. (2014), thus indi-
cates that early during infection in DCs, MDA5 and RIG-I are
inhibited through virus-induced DC-SIGN-Raf-1 signaling; later
during infection, however, when viral protein expression occurs,
the V protein of MV specifically keepsMDA5, but not RIG-I, in the
phosphorylated, repressed state.
To determine the contribution of MDA5-PP1 inhibition by the
MV-V protein to type I IFN suppression in DCs, we compared
IFN-b and ISG induction upon infection with WT virus or VDtail
virus (Figures 6B–6D). DCs infected with the VDtail virus had
markedly increased mRNA levels of Ifnb1, Mx1, and Isg15
compared to cells infected with WT virus, specifically when
DC-SIGN signaling was blocked using the Raf-1 inhibitor
GW5074, but not upon DMSO treatment (Figures 6B–6D).
Collectively, these results demonstrate that in DCs, MV uses
V-dependent and V-independent mechanisms to block RLR
signaling; in addition to RLR inhibition through DC-SIGN-Raf-1
signaling, the V protein is important for MV to block MDA5
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IFN antagonism. The V protein specifically targets MDA5 late
during infection, while DC-SIGN signaling through Raf-1 blocks
both RIG-I and MDA5 early during infection.
DISCUSSION
The Paramyxoviridae family encompasses several clinically rele-
vant human pathogens that pose a serious global health
concern. MV, a member of the genus Morbillivirus, continuously
causes high morbidity and mortality worldwide, the latter of
which is caused by its ability to induce a generalized suppression
of the immune system (Moss et al., 2004). It is known that the
immunosuppressive effect of MV is partly due to its ability to
potently antagonize type I IFN induction in various cell types,
including lung epithelial cells and immune cells. Similar to other
paramyxoviruses, the IFN antagonistic activity of MV is largely
due to its nonstructural V protein, a virulence factor that is not
required for virus replication in vitro (Schneider et al., 1997) but
enhances pathogenicity in vivo (Devaux et al., 2008; Valsamakis
et al., 1998). While it is well known that the V protein antagonizes
various host innate immune proteins, including MDA5 and
STAT1/2, the precise mechanisms and physiological relevance
of these virus-host interactions remain largely unknown. In this
study, we show that the V protein of MV blocks PP1a/g-medi-
ated dephosphorylation of MDA5, which keeps MDA5 in the
phosphorylated, inactive state. Despite the fact that PP1a/g
are responsible for both MDA5 and RIG-I dephosphorylation,
MV-V specifically blocked MDA5, but not RIG-I, dephosphoryla-
tion. In addition, the V protein of NiV, of the Henipavirus genus,
also robustly modulated the phosphorylation state of MDA5
at S88. Maintenance of MDA5 phosphorylation by MV-V and
NiV-V subsequently blocked the interaction of MDA5 with
MAVS, preventing downstream signaling and IFN induction. In
contrast, no appreciable enhancement of MDA5 phosphoryla-
tion was detected with PIV5-V, of the Rubulavirus genus. Our
study thus identifies an important mechanism of MDA5 inhibition
that is distinct from that previously described involving a direct
interaction with and disruption of the MDA5 ATP hydrolysis
domain. Given that paramyxoviruses are equipped with multiple
mechanisms to manipulate IFN receptor signaling, it is not sur-
prising that these viruses have also evolved multiple strategies
to block MDA5-mediated IFN induction. Our study, combined
with previous studies, indicates that whereas the V proteins of
some paramyxoviruses, such as PIV5, blockMDA5 by disrupting
its ATPase activity, the V proteins of other paramyxoviruses,
such as MV and NiV, suppress MDA5 activation through modu-
lating the MDA5 phosphorylation state.
Mechanistically, our study revealed a physical interaction of
the V protein of MV and NiV with the phosphatases PP1a/g. In
contrast, PIV5-V did not interact with PP1a/g. Binding of MV-V
to PP1 strongly inhibited the PP1-MDA5 interaction. MDA5-
PP1 binding was also strongly impaired in MV-infected, but not
poly(I:C)-stimulated, cells.
Since PP1 substrates or PP1-interacting proteins usually
possess defined consensus motifs that mediate binding (Roy
and Cyert, 2009), we searched for known PP1-binding se-
quences in various paramyxovirus V proteins. A conserved
PP1-binding motif 288RIWY291 was identified in the very C-termi-Cnal tail region of the MV-V protein. The PP1-binding motif in
MV-V was required for PP1 interaction and for MV-V’s inhibitory
effect on MDA5 dephosphorylation. In contrast, no known PP1-
bindingmotif was found in the V proteins of PIV5 or NiV, the latter
of which also efficiently interacted with PP1a/g. It is thus
tempting to speculate that the V protein of NiV, which evolved
in bats, interacts with PP1a/g utilizing an as-yet-unknown PP1-
binding motif. Alternatively, it is possible that PP1 binding of
NiV-V may be mediated by MDA5 or another cellular protein.
Further analyses will be required to define the molecular archi-
tecture of the NiV V-PP1 complex and the molecular mechanism
of how NiV-V blocks MDA5 activation by PP1. Furthermore,
future studies will be directed toward investigating the precise
details of how NiV-V and MV-V block the PP1-mediated activa-
tion of MDA5, but not RIG-I.
Several reports indicate that theVproteinofparamyxoviruses is
amultiphosphorylated protein (Lu et al., 2008; Ludlowet al., 2008;
Pfaller and Conzelmann, 2008; Shiell et al., 2003). Recent studies
showed that the V proteins utilize cellular kinases for their own
phosphorylation and that this strategy is employedby somepara-
myxoviruses to antagonize innate immunity. For example, the V
proteins of PIV5 and mumps virus were shown to compete with
IRF3 for phosphorylation by TBK1/IKKε, thereby abrogating
IRF3-induced gene expression (Lu et al., 2008). Since no phos-
phatase for V protein dephosphorylation has been identified, we
asked whether the MV-V protein serves as a PP1 substrate. Ex-
perimentsusingchemical inhibitors ofPP1andan in vitrodephos-
phorylation assay indicated that PP1 dephosphorylates MV-V. It
is conceivable that the targeting of cellular kinases (TBK1 and
IKKs) or phosphatases (PP1a/g), which play key roles in innate
signal transduction pathways, is a common theme of the para-
myxovirus V protein for innate immune suppression. However,
more detailed studies are needed to determine whether MV-V
indeed serves as a ‘‘decoy’’ substrate of PP1a/g, or whether V
dephosphorylation by PP1 is a critical part of MV replication.
The V proteins of paramyxoviruses have been shown to sup-
press IFN induction and IFN receptor signaling through a number
of different mechanisms (Bowie and Unterholzner, 2008; Hor-
vath, 2004); however, the physiological relevance and contribu-
tion of specific IFN antagonistic functions of the V proteins to
immune suppression remain largely undetermined. To determine
the relevance of PP1 antagonism for innate immune evasion, we
generated a rMV in which the PP1-binding motif in the V protein
had been deleted. This VDtail mutant virus was severely growth
impaired compared to the parental virus in human lung epithelial
cells, which correlated with its ability to robustly trigger IRF3
activation and enhance IFN induction compared to the parental
virus, indicating an important role of PP1 antagonism by the
MV-V protein for inhibiting type I IFN induction in epithelial cells.
Infection studies in primates or hCD150 transgenic mice are
needed to reveal the physiological role of PP1 antagonism in
V-mediated innate immune suppression in vivo.
We extended our studies to primary human DCs, which are
also key target cells of MV in vivo, to determine the contribution
of PP1 antagonism by MV-V in immune cells. In contrast to the
parental virus, the VDtail mutant virus efficiently triggered
MDA5 S88 dephosphorylation at 16 h.p.i., demonstrating that
the PP1 binding-deficient VDtail virus loses its ability to suppress
MDA5 dephosphorylation and activation. Interestingly, MV alsoell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc. 27
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points, but not at later time points during infection of DCs. At
this early time point during infection, MDA5 dephosphorylation
was also blocked in a V protein-independent manner. This early
V-independent inhibition of both RIG-I andMDA5was caused by
virus-induced PP1a/g suppression through activation of the DC-
SIGN-Raf1 signaling cascade (Mesman et al., 2014). This reveals
that in DCs, MV has evolved two mechanisms—V-dependent
and V-independent—for blocking the dephosphorylation-
dependent activation of RLRs, indicating the importance of
modulating this pathway. In the case of MDA5, specifically at
later time points when viral gene expression occurs, this involves
a direct interaction of the V protein with PP1a/g, as presented
here. In contrast, to block RIG-I and MDA5 dephosphorylation
at early time points in infection, MV activates DC-SIGN signaling,
which triggers Raf-1 kinase activation, ultimately also resulting in
PP1a/g inhibition. Since MV inhibited both RIG-I and MDA5 at
early time points but specifically blocked MDA5 activation at
later time points, it is tempting to speculate that these receptors
sense viral RNAs in DCs at different time points during MV
infection. While both RIG-I and MDA5 may contribute to RNA
detection at early time points, MDA5 may be the main sensor
for detecting viral RNA species generated later during MV infec-
tion. A similar model of sequential RLR activation was recently
proposed for West Nile virus infection (Errett et al., 2013). How-
ever, further studies are needed to determine the temporal
contribution of RIG-I and MDA5 to viral RNA sensing during
MV infection.
Taken together, these results demonstrate that PP1 antago-
nism is an important viral strategy for escaping RLR immune
signaling and also emphasize the vital role of PP1a and PP1g
in innate immune activation.
EXPERIMENTAL PROCEDURES
GST Pull-Down Assay, Immunoprecipitation, and Immunoblot
Analysis
Human embryonic kidney 293T (HEK293T) and A549-hCD150 cells were lysed
in NP-40 buffer (50 mM HEPES [pH 7.4], 150 mM NaCl, 1% [v/v] NP-40,
protease inhibitor cocktail [Sigma] and Ser/Thr phosphatase inhibitor cocktail
[Sigma]), followed by GST pull down, immunoprecipitation (IP), and western
blot analysis as previously described (Gack et al., 2007; Gack et al., 2010).
For V-PP1 binding, coIPs were rigorously washed with NP-40 lysis buffer con-
taining 1 M NaCl.
Antibodies
For immunoblotting, the following primary antibodies were used: anti-FLAG
(M2; 1:2,000; Sigma), anti-HA (1:2,000; clone HA-7; Sigma), anti-glutathione
S-transferase (anti-GST; 1:2,000; Sigma), anti-measles nucleoprotein [3E1]
(1:500; Abcam), anti-PP1a (1:2,000; Bethyl Laboratories), anti-PP1g
(1:2,000; Bethyl Laboratories), anti-MDA5 (1:1,000; Enzo Life Sciences),
anti-pan pSer antibody (1:500; Abcam), and anti-b-Actin (1:10,000; Abcam).
The phospho-specific pS88-MDA5, pS8-RIG-I, and pT170-RIG-I rabbit
polyclonal antibodies have been previously described (Maharaj et al., 2012;
Wies et al., 2013).
Luciferase Reporter Assay
HEK293T cells, seeded into 12-well plates, were transfected with 200 ng IFN-b
luciferase and 300 ng b-gal-expressing pGK-b-gal as well as 500 ng FLAG-
MDA5, 400 ng GST-MDA5 2CARD, and 500 ng V protein. At 48 hr posttrans-
fection, whole-cell lysates were subjected to a luciferase assay (Promega).
Luciferase values were normalized to b-galactosidase to measure transfection
efficiency.28 Cell Host & Microbe 16, 19–30, July 9, 2014 ª2014 Elsevier Inc.In Vitro Dephosphorylation Assay
MV-V-FLAG protein was purified from transfected HEK293T cells using anti-
FLAG M2 agarose (Sigma). IPs were washed extensively with RIPA buffer,
then twice with PBS. The in vitro MV-V protein dephosphorylation reaction
was carried out at 30C for 1 hr in phosphatase buffer (25 mM TRIS-HCl [pH
7.5], 150 mM NaCl, 5 mM dithiothreitol) using 0.1 units of PP1a protein (Milli-
pore). The reaction was stopped by adding SDS-Laemmli buffer. Samples
were subjected to SDS-PAGE, followed by immunoblot analysis.
Microscopy
Bright-field images of infected A549-hCD150 cells were taken on a Nikon
Eclipse Ti microscope.
Confocal Microscopy
HeLa cells were transfected with Lipofectamine 2000 (Life Technologies)
according to the manufacturer’s instructions. At 36 hr posttransfection, cells
were stained with 500 mM MitoTracker Alexa Fluor 633 (Life Technologies) in
Dulbecco’s modified Eagle’s medium (DMEM) for 30 min. Cells were fixed
with 2% (w/v) paraformaldehyde for 10 min and permeabilized with 0.1%
(v/v) Triton X-100, followed by blocking with 5% (v/v) bovine serum in PBS
for 1 hr. Cell preparation and confocal microscopy analysis were performed
as previously described (Gack et al., 2007). For immunostaining of FLAG-
PP1g and HA-MV-V, rabbit anti-FLAG (Sigma) and mouse anti-HA (clone
HA-7; Sigma) antibodies were used, followed by incubation with donkey
anti-rabbit Alexa Fluor 594 and donkey anti-mouse Alexa Fluor 488 (Life Tech-
nologies), respectively. Nuclei were stained with DAPI. Histogram profiles of
confocal images were created using the RGB Profiler function of ImageJ
(Schindelin et al., 2012).
A549-hCD150 cells were infected with rMVKSEGFP(3) WT or VDtail (moi 2) or
left uninfected. At 18 hr postinfection, cells were fixed and permeabilized as
described above, followed by blocking with 10% (v/v) goat serum in PBS for
1 hr. IRF3 was stained using a polyclonal rabbit anti-iRF3 (Santa Cruz Biotech-
nology) antibody and a donkey anti-rabbit Alexa Fluor 594 antibody (Abcam).
Nuclei were stained with DAPI. All laser scanning images were taken on an
Olympus IX8I confocal microscope.
Generation of a rMV Expressing EGFP and a Truncated V Protein
rMVKS is based on a wild-type genotype B3 virus isolated from PBMC
collected in 1997 from a severe measles case in Khartoum, Sudan (el Mubarak
et al., 2000). The details for generating the rMVKSEGFP(3) VDtail mutant virus
are provided in the Supplemental Experimental Procedures.
Quantitative Real-Time PCR
A549-hCD150 cells were infected with rMVKSEGFP(3) WT or VDtail virus at an
moi of 0.05. At 24 hr postinfection, cells were harvested, and total RNA was
extracted with the E.Z.N.A. HP Total RNA Kit (Omega). RNA was used for
qRT-PCR using SuperScript III Platinum One-Step Quantitative RT-PCR Sys-
tem with ROX kit (Invitrogen) with Ifnb1, Mx1, Oas1, Isg15, Ifi16, Mda5, and
Gapdh gene-specific primers (IDT) on a 7300 Real Time PCR System (Applied
Biosystems).
RIG-I and MDA5 Phosphorylation Analysis by Flow Cytometry
For determiningRIG-I andMDA5phosphorylation, immaturemonocyte-derived
humanDCs, obtained frombuffy coats of healthy donors (Sanguin) as described
in the Supplemental Experimental Procedures, were either left unstimulated or
preincubated with Raf-1 kinase inhibitor GW507427 (1 mM; Sigma) for 2 hr and
subsequently stimulated with poly(I:C)-LyoVec or infected with rMVKSEGFP(3)
WT or VDtail virus at the indicated moi. At 8 or 16 hr after infection, cells were
fixedwith4% (w/v) paraformaldehyde andpermeabilized in 90% (v/v)methanol.
Phosphorylation of endogenous RIG-I and MDA5 was assessed using
pS8-RIG-I, pT170-RIG-I, and pS88-MDA5 antibodies. After incubation with
PE-conjugated donkey anti-rabbit antibodies (Jackson ImmunoResearch
Laboratories), fluorescence was measured by flow cytometry. The studies on
primary human DCs were done in accordance with the ethical guidelines of
the Academic Medical Center at the University of Amsterdam.
Statistical Analysis
Statistical analysis was performed by unpaired, two-tailed Student’s t test.
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